|
1
|
Vasseur C and Baudin-Creuza V: Role of
alpha-hemoglobin molecular chaperone in the hemoglobin formation
and clinical expression of some hemoglobinopathies. Transfus Clin
Biol. 22:49–57. 2015.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Seakins M, Gibbs WN, Milner PF and Bertles
JF: Erythrocyte Hb-S concentration. An important factor in the low
oxygen affinity of blood in sickle cell anemia. J Clin Invest.
52:422–432. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hebbel RP, Osarogiagbon R and Kaul D: The
endothelial biology of sickle cell disease: inflammation and a
chronic vasculopathy. Microcirculation. 11:129–151. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lindsay P, Furie KL, Davis SM, Donnan GA
and Norrving B: World Stroke Organization global stroke services
guidelines and action plan. Int J Stroke. 9(Suppl A100): 4–13.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pegelow CH, Macklin EA, Moser FG, Wang WC,
Bello JA, Miller ST, Vichinsky EP, DeBaun MR, Guarini L, Zimmerman
RA, et al: Longitudinal changes in brain magnetic resonance imaging
findings in children with sickle cell disease. Blood. 99:3014–3018.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ohene-Frempong K, Weiner SJ, Sleeper LA,
Miller ST, Embury S, Moohr JW, Wethers DL, Pegelow CH and Gill FM:
Cerebrovascular accidents in sickle cell disease: rates and risk
factors. Blood. 91:288–294. 1998.PubMed/NCBI
|
|
7
|
Tarazi RA, Grant ML, Ely E and Barakat LP:
Neuropsychological functioning in preschool-age children with
sickle cell disease: the role of illness-related and psychosocial
factors. Child Neuropsychol. 13:155–172. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Balkaran B, Char G, Morris JS, Thomas PW,
Serjeant BE and Serjeant GR: Stroke in a cohort of patients with
homozygous sickle cell disease. J Pediatr. 120:360–366. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Moser FG, Miller ST, Bello JA, Pegelow CH,
Zimmerman RA, Wang WC, Ohene-Frempong K, Schwartz A, Vichinsky EP,
Gallagher D, et al: The spectrum of brain MR abnormalities in
sickle-cell disease: a report from the Cooperative Study of Sickle
Cell Disease. AJNR Am J Neuroradiol. 17:965–972. 1996.PubMed/NCBI
|
|
10
|
Ohene-Frempong K: Stroke in sickle cell
disease: demographic, clinical, and therapeutic considerations.
Semin Hematol. 28:213–219. 1991.PubMed/NCBI
|
|
11
|
McLaughlin JF and Ballas SK: High
mortality among children with sickle cell anemia and overt stroke
who discontinue blood transfusion after transition to an adult
program. Transfusion. Nov 23–2015.(Epub ahead of print). PubMed/NCBI
|
|
12
|
Sébire G, Tabarki B, Saunders DE, Leroy I,
Liesner R, Saint-Martin C, Husson B, Williams AN, Wade A and
Kirkham FJ: Cerebral venous sinus thrombosis in children: risk
factors, presentation, diagnosis and outcome. Brain. 128:477–489.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hess DC, Adams RJ and Nichols FT III:
Sickle cell anemia and other hemoglobinopathies. Semin Neurol.
11:314–328. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Prohovnik I, Hurlet-Jensen A, Adams R, De
Vivo D and Pavlakis SG: Hemodynamic etiology of elevated flow
velocity and stroke in sickle-cell disease. J Cereb Blood Flow
Metab. 29:803–810. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kirkham FJ, Calamante F, Bynevelt M,
Gadian DG, Evans JP, Cox TC and Connelly A: Perfusion magnetic
resonance abnormalities in patients with sickle cell disease. Ann
Neurol. 49:477–485. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kirkham FJ, Hewes DK, Prengler M, Wade A,
Lane R and Evans JP: Nocturnal hypoxaemia and
central-nervous-system events in sickle-cell disease. Lancet.
357:1656–1659. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Quinn CT and Ahmad N: Clinical correlates
of steady-state oxyhaemoglobin desaturation in children who have
sickle cell disease. Br J Haematol. 131:129–134. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Quinn CT, Variste J and Dowling MM:
Haemoglobin oxygen saturation is a determinant of cerebral artery
blood flow velocity in children with sickle cell anaemia. Br J
Haematol. 145:500–505. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fisher SA, Brunskill SJ, Doree C, Mathur
A, Taggart DP and Martin-Rendon E: Stem cell therapy for chronic
ischaemic heart disease and congestive heart failure. Cochrane
Database Syst Rev. 4:CD0078882014.PubMed/NCBI
|
|
20
|
DeBaun MR, Armstrong FD, McKinstry RC,
Ware RE, Vichinsky E and Kirkham FJ: Silent cerebral infarcts: a
review on a prevalent and progressive cause of neurologic injury in
sickle cell anemia. Blood. 119:4587–4596. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Steen RG, Fineberg-Buchner C, Hankins G,
Weiss L, Prifitera A and Mulhern RK: Cognitive deficits in children
with sickle cell disease. J Child Neurol. 20:102–107. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pegelow CH, Wang W, Granger S, Hsu LL,
Vichinsky E, Moser FG, Bello J, Zimmerman RA, Adams RJ, Brambilla
D, et al: Silent infarcts in children with sickle cell anemia and
abnormal cerebral artery velocity. Arch Neurol. 58:2017–2021. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Quinn CT, McKinstry RC, Dowling MM, Ball
WS, Kraut MA, Casella JF, Dlamini N, Ichord RN, Jordan LC, Kirkham
FJ, et al: Acute silent cerebral ischemic events in children with
sickle cell anemia. JAMA Neurol. 70:1–8. 2012.
|
|
24
|
Adams RJ, McKie VC, Hsu L, Files B,
Vichinsky E, Pegelow C, Abboud M, Gallagher D, Kutlar A, Nichols
FT, et al: Prevention of a first stroke by transfusions in children
with sickle cell anemia and abnormal results on transcranial
Doppler ultrasonography. N Engl J Med. 339:5–11. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wayne AS, Kevy SV and Nathan DG:
Transfusion management of sickle cell disease. Blood. 81:1109–1123.
1993.PubMed/NCBI
|
|
26
|
Ballas SK: Iron overload is a determinant
of morbidity and mortality in adult patients with sickle cell
disease. Semin Hematol. 38(Suppl 1): 30–36. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang W and Dwan K: Blood transfusion for
preventing primary and secondary stroke in people with sickle cell
disease. Cochrane Database Syst Rev. 11:CD0031462013.PubMed/NCBI
|
|
28
|
Smith-Whitley K and Thompson AA:
Indications and complications of transfusions in sickle cell
disease. Pediatr Blood Cancer. 59:358–364. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Adekile AD, Yacoub F, Gupta R, Sinan T,
Haider MZ, Habeeb Y, Al-Bloushi M and Moosa A: Silent brain
infarcts are rare in Kuwaiti children with sickle cell disease and
high Hb F. Am J Hematol. 70:228–231. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Benkerrou M, Delarche C, Brahimi L, Fay M,
Vilmer E, Elion J, Gougerot-Pocidalo MA and Elbim C: Hydroxyurea
corrects the dysregulated L-selectin expression and increased
H(2)O(2) production of polymorphonuclear neutrophils from patients
with sickle cell anemia. Blood. 99:2297–2303. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lagunju IA, Brown BJ and Sodeinde OO:
Stroke recurrence in Nigerian children with sickle cell disease
treated with hydroxyurea. Niger Postgrad Med J. 20:181–187.
2013.PubMed/NCBI
|
|
32
|
Walters MC, Patience M, Leisenring W,
Eckman JR, Scott JP, Mentzer WC, Davies SC, Ohene-Frempong K,
Bernaudin F, Matthews DC, et al: Bone marrow transplantation for
sickle cell disease. N Engl J Med. 335:369–376. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bhatia M and Walters MC: Hematopoietic
cell transplantation for thalassemia and sickle cell disease: past,
present and future. Bone Marrow Transplant. 41:109–117. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hanna J, Wernig M, Markoulaki S, Sun CW,
Meissner A, Cassady JP, Beard C, Brambrink T, Wu LC, Townes TM, et
al: Treatment of sickle cell anemia mouse model with iPS cells
generated from autologous skin. Science. 318:1920–1923. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rees DC, Williams TN and Gladwin MT:
Sickle-cell disease. Lancet. 376:2018–2031. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jordan L, Swerdlow P and Coates TD:
Systematic review of transition from adolescent to adult care in
patients with sickle cell disease. J Pediatr Hematol Oncol.
35:165–169. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang WC, Pavlakis SG, Helton KJ, McKinstry
RC, Casella JF, Adams RJ and Rees RC: BABY HUG Investigators: MRI
abnormalities of the brain in one-year-old children with sickle
cell anemia. Pediatr Blood Cancer. 51:643–646. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kwiatkowski JL, Zimmerman RA, Pollock AN,
Seto W, Smith-Whitley K, Shults J, Blackwood-Chirchir A and
Ohene-Frempong K: Silent infarcts in young children with sickle
cell disease. Br J Haematol. 146:300–305. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bernaudin F, Verlhac S, Coïc L, Lesprit E,
Brugières P and Reinert P: Long-term follow-up of pediatric sickle
cell disease patients with abnormal high velocities on transcranial
Doppler. Pediatr Radiol. 35:242–248. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Casella JF, King AA, Barton B, White DA,
Noetzel MJ, Ichord RN, Terrill C, Hirtz D, McKinstry RC, Strouse
JJ, et al: Design of the silent cerebral infarct transfusion (SIT)
trial. Pediatr Hematol Oncol. 27:69–89. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kral MC, Brown RT, Connelly M, Curé JK,
Besenski N, Jackson SM and Abboud MR: Radiographic predictors of
neurocognitive functioning in pediatric Sickle Cell disease. J
Child Neurol. 21:37–44. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Emam AT, Ali AM and Babikr MA: Magnetic
resonance spectroscopy of the brain in children with sickle cell
disease. Neurosciences (Riyadh). 14:364–367. 2009.PubMed/NCBI
|
|
43
|
Brown RT, Armstrong FD and Eckman JR:
Neurocognitive aspects of pediatric sickle cell disease. J Learn
Disabil. 26:33–45. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gold JI, Johnson CB, Treadwell MJ, Hans N
and Vichinsky E: Detection and assessment of stroke in patients
with sickle cell disease: neuropsychological functioning and
magnetic resonance imaging. Pediatr Hematol Oncol. 25:409–421.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
van der Land V, Hijmans CT, de Ruiter M,
Mutsaerts HJ, Cnossen MH, Engelen M, Majoie CB, Nederveen AJ,
Grootenhuis MA and Fijnvandraat K: Volume of white matter
hyperintensities is an independent predictor of intelligence
quotient and processing speed in children with sickle cell disease.
Br J Haematol. 168:553–556. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Schatz J, Brown RT, Pascual JM, Hsu L and
DeBaun MR: Poor school and cognitive functioning with silent
cerebral infarcts and sickle cell disease. Neurology. 56:1109–1111.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Berg C, Edwards DF and King A: Executive
function performance on the children's kitchen task assessment with
children with sickle cell disease and matched controls. Child
Neuropsychol. 18:432–448. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Vichinsky EP, Neumayr LD, Gold JI, Weiner
MW, Rule RR, Truran D, Kasten J, Eggleston B, Kesler K, McMahon L,
et al: Neuropsychological Dysfunction and Neuroimaging Adult Sickle
Cell Anemia Study Group: Neuropsychological dysfunction and
neuroimaging abnormalities in neurologically intact adults with
sickle cell anemia. JAMA. 303:1823–1831. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Thompson RJ Jr, Gustafson KE, Bonner MJ
and Ware RE: Neurocognitive development of young children with
sickle cell disease through three years of age. J Pediatr Psychol.
27:235–244. 2002. View Article : Google Scholar : PubMed/NCBI
|
